Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Yeast tRNAAsp-aspartyl-tRNA synthetase: the crystalline complex.
Moras D, Lorber B, Romby P, Ebel JP, Giegé R, Lewit-Bentley A, Roth M. Moras D, et al. Among authors: roth m. J Biomol Struct Dyn. 1983 Oct;1(1):209-23. doi: 10.1080/07391102.1983.10507435. J Biomol Struct Dyn. 1983. PMID: 6401112 Review.
[ChatGPT and the German board examination for ophthalmology: an evaluation].
Yaïci R, Cieplucha M, Bock R, Moayed F, Bechrakis NE, Berens P, Feltgen N, Friedburg D, Gräf M, Guthoff R, Hoffmann EM, Hoerauf H, Hintschich C, Kohnen T, Messmer EM, Nentwich MM, Pleyer U, Schaudig U, Seitz B, Geerling G, Roth M. Yaïci R, et al. Among authors: roth m. Ophthalmologie. 2024 May 27. doi: 10.1007/s00347-024-02046-0. Online ahead of print. Ophthalmologie. 2024. PMID: 38801461 German.
Exploring Iodide and Hydrogen Sulfide as ROS Scavengers to Delay Acute Rejection in MHC-Defined Vascularized Composite Allografts.
Tratnig-Frankl P, Andrews AR, Berkane Y, Guinier C, Goutard M, Lupon E, Lancia HH, Morrison ML, Roth MB, Randolph MA, Cetrulo CL Jr, Lellouch AG. Tratnig-Frankl P, et al. Among authors: roth mb. Antioxidants (Basel). 2024 Apr 26;13(5):531. doi: 10.3390/antiox13050531. Antioxidants (Basel). 2024. PMID: 38790636 Free PMC article.
Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Gibson A, Nunez C, Robusto L, Kammerer B, Garcia M, Roth M, Sheth R, Tewari P, Hittle A, Toepfer L, Torres R, Short NJ, Jabbour E, Jain N, Cuglievan B, McCall D. Gibson A, et al. Among authors: roth m. Haematologica. 2024 May 23. doi: 10.3324/haematol.2023.284950. Online ahead of print. Haematologica. 2024. PMID: 38779719 Free article.
2,855 results